Publication

Nonadherence to statins: individualized intervention strategies outside the pill box

Lansberg, P., Lee, A., Lee, Z-V., Subramaniam, K. & Setia, S., 2018, In : Vascular health and risk management. 14, p. 91-102 12 p.

Research output: Contribution to journalReview articleAcademicpeer-review

APA

Lansberg, P., Lee, A., Lee, Z-V., Subramaniam, K., & Setia, S. (2018). Nonadherence to statins: individualized intervention strategies outside the pill box. Vascular health and risk management, 14, 91-102. https://doi.org/10.2147/VHRM.S158641

Author

Lansberg, Peter ; Lee, Andre ; Lee, Zhen-Vin ; Subramaniam, Kannan ; Setia, Sajita. / Nonadherence to statins : individualized intervention strategies outside the pill box. In: Vascular health and risk management. 2018 ; Vol. 14. pp. 91-102.

Harvard

Lansberg, P, Lee, A, Lee, Z-V, Subramaniam, K & Setia, S 2018, 'Nonadherence to statins: individualized intervention strategies outside the pill box' Vascular health and risk management, vol. 14, pp. 91-102. https://doi.org/10.2147/VHRM.S158641

Standard

Nonadherence to statins : individualized intervention strategies outside the pill box. / Lansberg, Peter; Lee, Andre; Lee, Zhen-Vin; Subramaniam, Kannan; Setia, Sajita.

In: Vascular health and risk management, Vol. 14, 2018, p. 91-102.

Research output: Contribution to journalReview articleAcademicpeer-review

Vancouver

Lansberg P, Lee A, Lee Z-V, Subramaniam K, Setia S. Nonadherence to statins: individualized intervention strategies outside the pill box. Vascular health and risk management. 2018;14:91-102. https://doi.org/10.2147/VHRM.S158641


BibTeX

@article{119b6d0812644ebeb743d672caa22aef,
title = "Nonadherence to statins: individualized intervention strategies outside the pill box",
abstract = "Poor adherence to statin therapy is linked to significantly increased risk of cardiovascular events and death. Unfortunately, adherence to statins is far from optimal. This is an alarming concern for patients prescribed potentially life-saving cholesterol-lowering medication, especially for those at high risk of cardiovascular events. Research on statin adherence has only recently garnered broader attention; hence, major reasons unique to adherence to statin therapy need to be identified as well as suggestions for countermeasures. An integrated approach to minimizing barriers and enhancing facilitation at the levels of the patient, provider, and health system can help address adherence issues. Health care professionals including physicians, pharmacists, and nurses have an obligation to improve patient adherence, as routine care. In order to achieve sustained results, a multifaceted approach is indispensable.",
keywords = "cardiovascular disease, nonadherence, nocebo, myopathy, statins, ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE, CORONARY HEART-DISEASE, RANDOMIZED CONTROLLED-TRIAL, MEDICATION ADHERENCE, PRIMARY PREVENTION, IMPROVE ADHERENCE, ROSUVASTATIN PHARMACOKINETICS, MYOCARDIAL-INFARCTION, LOWERING MEDICATIONS, AUTOIMMUNE MYOPATHY",
author = "Peter Lansberg and Andre Lee and Zhen-Vin Lee and Kannan Subramaniam and Sajita Setia",
year = "2018",
doi = "10.2147/VHRM.S158641",
language = "English",
volume = "14",
pages = "91--102",
journal = "Vascular health and risk management",
issn = "1176-6344",
publisher = "DOVE MEDICAL PRESS LTD",

}

RIS

TY - JOUR

T1 - Nonadherence to statins

T2 - individualized intervention strategies outside the pill box

AU - Lansberg, Peter

AU - Lee, Andre

AU - Lee, Zhen-Vin

AU - Subramaniam, Kannan

AU - Setia, Sajita

PY - 2018

Y1 - 2018

N2 - Poor adherence to statin therapy is linked to significantly increased risk of cardiovascular events and death. Unfortunately, adherence to statins is far from optimal. This is an alarming concern for patients prescribed potentially life-saving cholesterol-lowering medication, especially for those at high risk of cardiovascular events. Research on statin adherence has only recently garnered broader attention; hence, major reasons unique to adherence to statin therapy need to be identified as well as suggestions for countermeasures. An integrated approach to minimizing barriers and enhancing facilitation at the levels of the patient, provider, and health system can help address adherence issues. Health care professionals including physicians, pharmacists, and nurses have an obligation to improve patient adherence, as routine care. In order to achieve sustained results, a multifaceted approach is indispensable.

AB - Poor adherence to statin therapy is linked to significantly increased risk of cardiovascular events and death. Unfortunately, adherence to statins is far from optimal. This is an alarming concern for patients prescribed potentially life-saving cholesterol-lowering medication, especially for those at high risk of cardiovascular events. Research on statin adherence has only recently garnered broader attention; hence, major reasons unique to adherence to statin therapy need to be identified as well as suggestions for countermeasures. An integrated approach to minimizing barriers and enhancing facilitation at the levels of the patient, provider, and health system can help address adherence issues. Health care professionals including physicians, pharmacists, and nurses have an obligation to improve patient adherence, as routine care. In order to achieve sustained results, a multifaceted approach is indispensable.

KW - cardiovascular disease

KW - nonadherence

KW - nocebo

KW - myopathy

KW - statins

KW - ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE

KW - CORONARY HEART-DISEASE

KW - RANDOMIZED CONTROLLED-TRIAL

KW - MEDICATION ADHERENCE

KW - PRIMARY PREVENTION

KW - IMPROVE ADHERENCE

KW - ROSUVASTATIN PHARMACOKINETICS

KW - MYOCARDIAL-INFARCTION

KW - LOWERING MEDICATIONS

KW - AUTOIMMUNE MYOPATHY

U2 - 10.2147/VHRM.S158641

DO - 10.2147/VHRM.S158641

M3 - Review article

VL - 14

SP - 91

EP - 102

JO - Vascular health and risk management

JF - Vascular health and risk management

SN - 1176-6344

ER -

ID: 71234595